Our mission, scope, and commitment to advancing life science research.
The Journal of Life Science (JLS) is an international, peer-reviewed, open access journal dedicated to publishing high-quality original research, review articles, and short communications across the breadth of the life sciences. Founded in 2013, JLS serves as a platform for researchers, clinicians, and educators to share discoveries that advance our understanding of living systems.
We are committed to scientific rigor, transparency, and accessibility. By maintaining an open access model, we ensure that research findings are freely available to scientists, students, and the public worldwide — removing barriers to knowledge and accelerating the pace of discovery.
Our editorial philosophy emphasizes methodological soundness, reproducibility, and the potential for research to contribute meaningfully to its field. We welcome submissions from researchers at all career stages and from all regions of the world.
JLS publishes research spanning the full spectrum of the life sciences, including but not limited to:
The Journal of Life Science is indexed and abstracted in the following major databases:
JLS is a fully open access journal. All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Processing Charges (APCs) are used to cover the costs of peer review management, copyediting, typesetting, and digital archiving. Fee waivers are available for authors from low- and middle-income countries and for submissions of exceptional merit.
The Journal of Life Science is committed to upholding the highest standards of publication ethics. We follow the guidelines established by the Committee on Publication Ethics (COPE) and adhere to the principles outlined in the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work.
All submitted manuscripts undergo rigorous peer review. The journal maintains a zero-tolerance policy for fabrication, falsification, plagiarism, and duplicate submission. Authors are required to disclose all potential conflicts of interest and funding sources.
Our editors and reviewers are held to strict confidentiality standards. Any concerns about ethical violations should be reported to the Editor-in-Chief at ethics@journaloflifescience.org.
The Journal of Life Science was founded in 2013 by a consortium of researchers from leading universities who recognized the need for a high-quality, open access journal that could bridge the gap between specialized subdisciplines within the life sciences.
Since its inception, JLS has published over 1,200 articles from researchers in more than 60 countries. The journal received its first Impact Factor in 2017 and has been continuously indexed in Scopus and Web of Science since 2016. In 2022, JLS was accepted into PubMed/MEDLINE, reflecting the growing recognition of the journal's commitment to publishing impactful, methodologically rigorous research.
Today, JLS is supported by an international editorial board of over 40 active researchers and processes more than 500 submissions annually, with an average time to first decision of 28 days.